Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: Comparison of maximum and mean choline values

Neurosurgery

Volumn 65, Issue 5, 2009, Pages 908-913

  Senft, Christian ^a   Hattingen, Elke ^a   Pilatus, Ulrich ^a   Franz, Kea ^a   Schänzer, Anne ^a   Lanfermann, Heinrich ^a   Seifert, Volker ^a   Gasser, Thomas ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Brain tumor; Choline; Magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE;

ADULT; ARTICLE; CANCER SURGERY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RANK SUM TEST; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; STEREOTACTIC BIOPSY; WORLD HEALTH ORGANIZATION;

ADULT; BRAIN NEOPLASMS; CHOLINE; CREATINE; GLIOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE SPECTROSCOPY; PROTONS;

EID: 70350316378     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000356982.82378.BA     Document Type: Article

References (31)

1. Alimenti A, Delavelle J, Lazeyras F, Yilmaz H, Dietrich PY, de Tribolet N, Lövblad KO: Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomas. Eur Neurol 58:198-209, 2007.
2. Bauman G, Shaw EG: Low-grade glioma: Current management and controversies. Clin Adv Hematol Oncol 1:546-553, 2003.
3. Fayed N, Modrego PJ: The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours. J Neurooncol 72:261-265, 2005.
4. Fayed N, Morales H, Modrego PJ, Pina MA: Contrast/noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas. Acad Radiol 13:728-737, 2006.
5. Hattingen E, Raab P, Franz K, Lanfermann H, Setzer M, Gerlach R, Zanella FE, Pilatus U: Prognostic value of choline and creatine in WHO grade II gliomas. Neuroradiology 50:759-767, 2008.
6. Hattingen E, Raab P, Franz K, Zanella FE, Lanfermann H, Pilatus U: Myoinositol: A marker of reactive astrogliosis in glial tumors? NMR Biomed 21:233-241, 2008.
7. Herminghaus S, Dierks T, Pilatus U, Möller-Hartmann W, Wittsack J, Marquardt G, Labisch C, Lanfermann H, Schlote W, Zanella FE: Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data. J Neurosurg 98:74-81, 2003.
8. Hoang-Xuan K, Capelle L, Kujas M, Taillibert S, Duffau H, Lejeune J, Polivka M, Crinière E, Marie Y, Mokhtari K, Carpentier AF, Laigle F, Simon JM, Cornu P, Broët P, Sanson M, Delattre JY: Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 22:3133-3138, 2004.
9. Hwang JH, Egnaczyk GF, Ballard E, Dunn RS, Holland SK, Ball WS Jr: Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am J Neuroradiol 19:535-540, 1998.
10. Kleihues P, Cavenee W (eds): Pathology and Genetics of Tumours of the Nervous System. Lyon, IARC Press, 2000.
11. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D: Glioma grading: Sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989-1998, 2003.
12. Li X, Lu Y, Pirzkall A, McKnight T, Nelson SJ: Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 16:229-237, 2002.
13. Matsumura A, Isobe T, Anno I, Takano S, Kawamura H: Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study. J Clin Neurosci 12:416-420, 2005.
14. McKnight TR, Lamborn KR, Love TD, Berger MS, Chang S, Dillon WP, Bollen A, Nelson SJ: Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. J Neurosurg 106:660-666, 2007.
15. Möller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, Zanella FE: Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371-381, 2002.
16. Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BC, Mengeot MM, Moser E, Padavic-Shaller KA, Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogl TJ, Wicklow K, Zimmerman RA: Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study. J Neurosurg 84:449-458, 1996. (Pubitemid 26062870)
17. Nicholas MK: Glioblastoma multiforme: Evidence-based approach to therapy. Expert Rev Anticancer Ther 7:S23-S27, 2007.
18. Opstad KS, Ladroue C, Bell BA, Griffiths JR, Howe FA: Linear discriminant analysis of brain tumour (1)H MR spectra: A comparison of classification using whole spectra versus metabolite quantification. NMR Biomed 20:763-770, 2007.
19. Panigrahy A, Krieger MD, Gonzalez-Gomez I, Liu X, McComb JG, Finlay JL, Nelson MD Jr, Gilles FH, Blüml S: Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: Preoperative diagnosis and characterization. AJNR Am J Neuroradiol 27:560-572, 2006.
20. Provencher SW: Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679, 1993.
21. Schiff D, Brown PD, Giannini C: Outcome in adult low-grade glioma: The impact of prognostic factors and treatment. Neurology 69:1366-1373, 2007.
22. Setzer M, Herminghaus S, Marquardt G, Tews DS, Pilatus U, Seifert V, Zanella F, Lanfermann H: Diagnostic impact of proton MR-spectroscopy versus image-guided stereotactic biopsy. Acta Neurochir (Wien) 149:379-386, 2007.
23. Shimizu H, Kumabe T, Shirane R, Yoshimoto T: Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 21:659-665, 2000.
24. Stadlbauer A, Gruber S, Nimsky C, Fahlbusch R, Hammen T, Buslei R, Tomandl B, Moser E, Ganslandt O: Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology 238:958-969, 2006.
25. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, DiChiro G: Increased choline signal coinciding with malignant degeneration of cerebral gliomas: A serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87:516-524, 1997. (Pubitemid 27430397)
26. van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, Malmström PO, Collette L, Piérart M, Mirimanoff R, Karim AB; EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council: Long-term efficacy of early versus delayed radiotherapy for lowgrade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomised trial. Lancet 366:985-990, 2005.
27. Vuori K, Kankaanranta L, Häkkinen AM, Gaily E, Valanne L, Granström ML, Joensuu H, Blomstedt G, Paetau A, Lundbom N: Low-grade gliomas and focal cortical developmental malformations: Differentiation with proton MR spectroscopy. Radiology 230:703-708, 2004.
28. White ML, Zhang Y, Kirby P, Ryken TC: Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas? AJNR Am J Neuroradiol 26:784-790, 2005.
29. Wiedermann D, Schuff N, Matson GB, Soher BJ, Du AT, Maudsley AA, Weiner MW: Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: Metabolite distributions and reliability. Magn Reson Imaging 19:1073-1080, 2001.
30. Xu M, See SJ, Ng WH, Arul E, Back MF, Yeo TT, Lim CC: Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery 56:919-926, 2005.
31. Yang D, Korogi Y, Sugahara T, Kitajima M, Shigematsu Y, Liang L, Ushio Y, Takahashi M: Cerebral gliomas: Prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 44:656-666, 2002.